The global Steam Inhaler Devices Market is estimated to be valued at US$ 2.5 Bn or Mn in 2023 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Steam inhaler devices are drug-free respite care products which help deliver moist heat medication-free relief from nasal and chest congestion associated with cold, flu or allergies. Steam inhaler devices work by heating water to produce steam which can help loosen mucus and clear nasal/chest congestion. The steam moisturizes the respiratory tract and provides temporary relief without any side effects.
Market Overview:
Steam inhaler devices are portable steam vaporizers that allow easy and hassle-free administration of steam treatment for respiratory ailments from the comfort of one's home. Wide range of steam inhaler devices are available including electrically heated and battery powered models for travel use.
Market key trends:
Growing preference for natural and non-drug remedies for cold, flu and asthma among consumers is propelling the steam inhaler devices market. Additionally, rising air pollution levels and incidence of allergy and flu worldwide are triggering higher demands for steam inhalers. Low cost of ownership and ease of use of steam inhalers compared to nebulizers also contributes to their increasing adoption. Home healthcare trend and rising health and wellness consciousness further complements growth of this market.
Segment Analysis
The global Steam Inhaler Devices Market Size is dominated by the electric steam inhaler sub-segment. Electric steam inhalers are more convenient to use as compared to nonelectric steam inhalers as they do not require boiling water. They heat water quickly to produce steam for inhalation. This sub-segment accounts for around 60% of the total steam inhaler devices market share due to the convenience offered by these devices.
Key Takeaways
The global steam inhaler devices market is expected to witness high growth, exhibiting CAGR of 7.7% over the forecast period, due to increasing prevalence of respiratory diseases.
Regional analysis
North America dominated the global steam inhaler devices market in 2023, accounting for around 35% share. This is attributed to the rising cases of respiratory issues such as asthma in the region. Asia Pacific is expected to be the fastest growing region during the forecast period owing to increasing healthcare expenditure and growing geriatric population.
Key players
Key players operating in the steam inhaler devices market include Vicks, MyPurMist, Gurin, Uniclife, HealthSmart, Veridian Healthcare, Vanker, Leica Biosystems, Guardian Technologies, Kaz, Honeywell, Bionix, Invacare, Breathe-ezy, Austin Air Systems, Drive DeVilbiss Healthcare, CareFusion, Cipla, GlaxoSmithKline, and PARI Respiratory Equipment. Vicks dominates the market with over 20% share due its large product portfolio and strong brand presence.
Read Our More Blogs : https://www.rapidwebwire.com/steam-inhaler-devices-market-size-share-analysis-2023-2030/
Comments
0 comment